3Fraser IS,Critchley HO,Broder M,et al.The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding[J].Semin Reprod Med,2011,29:383-390.
4Munro MG,Critchley HO,Fraser IS.The FIGO classification of causes of abnormal uterine bleeding in the reproductive years[J].Fertil Steril,2011,95:2204-2208.
6Salim S,Won H,Nesbitt-Hawes E,et al.Diagnosis andmanagement of endometrial polyps:a critical review of theliterature[J].J Minim Invasive Gynecol,2011,18:569-581.
7Gardner F J,Konje JC,Bell SC,et al.Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial[J].Gynecol Oncol,2009,114:452-456.
8Weiss G,Maseelall P,Schott LL,et al.Adenomyosis a variant,not a disease? Evidence from hysterectomized menopausal women in the Study of Women' s Health Across the Nation (SWAN)[J].Fertil Steril,2009,91:201-206.
9Morelli M,Rocca ML,Venturella R,et al.Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis:a retrospective study[J].Gynecol Endocrinol,2013,29:305-308.
